EDGAR Filing Documents for 0001144204-15-008640

Form SC 13G - Statement of acquisition of beneficial ownership by individuals:

SEC Accession No. 0001144204-15-008640

Filing Date

2015-02-13

Accepted

2015-02-13 06:03:29

Documents

Group Members

FLORIAN SCHONHARTINGNB FP INVESTMENT II K/SNB FP INVESTMENT K/SNORDIC BIOTECH GENERAL PARTNER APSNORDIC BIOTECH OPPORTUNITY FUND K/S

Document Format Files

Seq	Description	Document	Type	Size
1	SC 13G	v401212_sc13g.htm	SC 13G	93557
2	EXHIBIT 1	v401212_ex1.htm	EX-99.1	12382
	Complete submission text file	0001144204-15-008640.txt		107540

Mailing Address OSTERGADE 5, 3RD FLOOR, DK-1100 COPENHAGEN K G7 -----

Business Address OSTERGADE 5, 3RD FLOOR, DK-1100 COPENHAGEN K G7 ----- 45 70 20 12 63

Nordic Biotech K/S (Filed by) CIK: 0001360542 (see all company filings)

IRS No.: 000000000
Type: SC 13G

Mailing Address ?STERGADE 24A, 1 COPENHAGEN G7 1100

Business Address ?STERGADE 24A, 1 COPENHAGEN G7 1100 0114533444242

Forward Pharma A/S (Subject) CIK: 0001604924 (see all company filings)